Index by author
January 01, 2021; Volume 88,Issue 1
Makin, Vinni
- You have accessThe role of SGLT-2 inhibitors in managing type 2 diabetesYumiko Tsushima, MD, M. Cecilia Lansang, MD, MPH and Vinni Makin, MBBS, MD, FACECleveland Clinic Journal of Medicine January 2021, 88 (1) 47-58; DOI: https://doi.org/10.3949/ccjm.88a.20088
These drugs improve glycemic control and offer cardiovascular and metabolic benefits.
Mandell, Brian F.
- You have accessThe Clinic and the Journal: Respecting the past and welcoming the futureBrian F. Mandell, MD, PhDCleveland Clinic Journal of Medicine January 2021, 88 (1) 6-8; DOI: https://doi.org/10.3949/ccjm.88b.01021
This year is the 100th anniversary of the founding of Cleveland Clinic.
Mehdi, Ali
- You have accessSGLT-2 inhibitors: A new era in managing diabetic kidney disease starts nowJonathan J. Taliercio, DO, George Thomas, MD, Georges N. Nakhoul, MD, MEd, Tushar J. Vachharajani, MD and Ali Mehdi, MD, MEdCleveland Clinic Journal of Medicine January 2021, 88 (1) 59-63; DOI: https://doi.org/10.3949/ccjm.88a.20190
Randomized controlled trials of these new agents had positive outcomes.